Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3188 (MIR3188) is a small (typically ~22 nucleotides), endogenous non-coding RNA molecule in humans that plays a regulatory role in cell biology by binding to messenger RNAs and inhibiting their translation or promoting their degradation. In hepatocellular carcinoma, MIR3188 has been shown to regulate cell proliferation and apoptosis by targeting the chemokine gene CXCL14, implicating it in tumor progression. Like other microRNAs, MIR3188 is generated from a longer primary transcript via the canonical microRNA biogenesis pathway, involving DROSHA and DICER enzymes for processing. Its broader function includes modulation of gene expression networks critical for development, disease, and cellular homeostasis[1][2][3][6].
RNA silencing: Binds to target mRNA (such as CXCL14 in hepatocellular carcinoma), leading to repression or degradation of that transcript. Translational inhibition: Prevents translation of specific protein-coding genes by binding to their mRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3188 (MIR3188).